Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
92.50    0.00 (0.00%)
Bid:
90.00
Ask:
95.00
Spread: 5.00 (5.556%)
Market Cap: £6.08m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Form 8 (OPD) - Crimson Tide plc

19 Feb 2025 16:30

RNS Number : 7508X
Crimson Tide PLC
19 February 2025
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Crimson Tide plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Crimson Tide plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

18 February 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

10p Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

 

NIL

 

(2) Cash-settled derivatives:

 

NIL

 

NIL

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

 

NIL

 

 

TOTAL:

NIL

 

NIL

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Ordinary Shares of 10 pence each in the capital of the Company

 

Director

Number of Ordinary Shares

% of issued share capital

Jacqueline Daniell

16,722

0.25%

Luke Jeffrey

73,251

1.11%

Pieter Hurter

885

0.01%

(b) Rights to subscribe for Ordinary Shares of 10 pence each in the capital of theCompany

Director

Type

Number of options

Exercise price

Date of grant

Vesting date from

Expiry date

Luke Jeffrey

EMI options

75,000

£3.35

22/12/20

23/12/23

23/12/30

 

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

19/02/2025

Contact name:

Pieter Hurter

Telephone number:

(+44) 1892 542 444

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEMZGMZVLLGKZM
Date   Source Headline
9th Jun 20267:00 amRNS-RNew contract trials: Sim Trava and DW Baking
5th Jun 202612:26 pmRNSHolding(s) in Company
5th May 20267:00 amRNSYear End Trading Update
24th Apr 20267:00 amRNSAIM Director Disclosure Update
2nd Apr 20267:00 amRNS-RNew Contract Wins
9th Mar 202610:00 amRNSConcert Party Update
26th Feb 20267:00 amRNSNon-Executive Director Appointments
18th Feb 20267:00 amRNS-RRenewal of Contract
23rd Jan 20267:00 amRNSChange of Non-Executive Director
29th Dec 20259:21 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSCustomer Contracts Update
4th Dec 20255:43 pmRNSHolding(s) in Company
27th Nov 20257:00 amRNSDirector/PDMR Shareholding - Grant of Options
19th Nov 20257:00 amRNSInterim Results
10th Nov 20253:14 pmRNSContract Renewal with Major Global Retailer
3rd Nov 20254:20 pmRNSHolding(s) in Company
31st Oct 20252:46 pmRNSResult of AGM
31st Oct 20259:28 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSAGM Statement
27th Oct 20254:45 pmRNSHolding(s) in Company
27th Oct 20254:43 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSAudited Full Year Results
29th Sep 20257:00 amRNSUpdate on Audited Results
22nd Jul 20257:00 amRNSAppointment of Chief Executive Officer
14th Jul 20252:40 pmRNSHolding(s) in Company
7th Jul 20257:00 amRNSContract Renewal with Major UK Wholesaler
4th Jul 20257:00 amRNSAppointment of Finance Director
12th Jun 202510:46 amRNSHolding(s) in Company
5th Jun 20257:00 amRNSAppointment of Chair, Nominated Adviser and Broker
30th May 20257:00 amRNSSecond Interim Results
29th May 20257:00 amRNSContract Renewal with Major British Supermarket
6th May 20257:00 amRNSChange of Accounting Reference Date
15th Apr 20253:58 pmRNSBoard Appointment
26th Mar 202511:00 amRNSBoard Changes
20th Mar 20252:29 pmRNSBoard Change
20th Mar 202512:36 pmRNSForm 8.5 (EPT/RI) - Amendment
20th Mar 202510:25 amRNSForm 8.5 (EPT/RI)
19th Mar 202511:50 amRNSResults of Court Meeting and General Meeting
18th Mar 20259:35 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 20253:06 pmGNWForm 8.3 - Crimson Tide Plc
17th Mar 202512:00 pmRNSForm 8.5 (EPT/RI)
14th Mar 20253:05 pmGNWForm 8.3 - Crimson Tide Plc
14th Mar 202511:58 amRNSForm 8.5 (EPT/RI)
12th Mar 202512:05 pmRNSForm 8.5 (EPT/RI)
12th Mar 20259:23 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 202510:32 amRNSForm 8.5 (EPT/RI)
11th Mar 20257:00 amRNSOffer Update
10th Mar 202512:01 pmRNSForm 8.5 (EPT/RI)
7th Mar 202512:23 pmRNSForm 8.3 - Crimson Tide plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.